Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation

Arthritic disease is one of the most common diseases in adults and a leading cause of joint degeneration. Dexibuprofen (DEX) is routinely used for the treatment of rheumatoid arthritis, acute postoperative pain, primary dysmenorrheal, and in lower back pain. However, it is poorly water soluble with...

Full description

Bibliographic Details
Published in:COLLOIDS AND SURFACES B-BIOINTERFACES
Main Authors: Munir, Rabia; Khan, Ikram Ullah; Kamal, Yousaf; Asghar, Sajid; Irfan, Muhammad; Alshammari, Abdulrahman; Asif, Muhammad; Albekairi, Norah A.; Shah, Pervaiz Akhtar; Khalid, Ikrima; Munir, Muhammad Rehan; Khalid, Syed Haroon
Format: Article
Language:English
Published: ELSEVIER 2025
Subjects:
Online Access:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-recordWOS:001375588800001
author Munir
Rabia; Khan
Ikram Ullah; Kamal
Yousaf; Asghar
Sajid; Irfan
Muhammad; Alshammari
Abdulrahman; Asif
Muhammad; Albekairi
Norah A.; Shah
Pervaiz Akhtar; Khalid
Ikrima; Munir
Muhammad Rehan; Khalid
Syed Haroon
spellingShingle Munir
Rabia; Khan
Ikram Ullah; Kamal
Yousaf; Asghar
Sajid; Irfan
Muhammad; Alshammari
Abdulrahman; Asif
Muhammad; Albekairi
Norah A.; Shah
Pervaiz Akhtar; Khalid
Ikrima; Munir
Muhammad Rehan; Khalid
Syed Haroon
Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
Biophysics; Chemistry; Materials Science
author_facet Munir
Rabia; Khan
Ikram Ullah; Kamal
Yousaf; Asghar
Sajid; Irfan
Muhammad; Alshammari
Abdulrahman; Asif
Muhammad; Albekairi
Norah A.; Shah
Pervaiz Akhtar; Khalid
Ikrima; Munir
Muhammad Rehan; Khalid
Syed Haroon
author_sort Munir
spelling Munir, Rabia; Khan, Ikram Ullah; Kamal, Yousaf; Asghar, Sajid; Irfan, Muhammad; Alshammari, Abdulrahman; Asif, Muhammad; Albekairi, Norah A.; Shah, Pervaiz Akhtar; Khalid, Ikrima; Munir, Muhammad Rehan; Khalid, Syed Haroon
Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
COLLOIDS AND SURFACES B-BIOINTERFACES
English
Article
Arthritic disease is one of the most common diseases in adults and a leading cause of joint degeneration. Dexibuprofen (DEX) is routinely used for the treatment of rheumatoid arthritis, acute postoperative pain, primary dysmenorrheal, and in lower back pain. However, it is poorly water soluble with compromised bioavailability, and hence has limited therapeutic activity. In order to overcome these issues, we studied the formulation and characterization of nanoemulsion based system i.e nanoemulgel of DEX. This study aimed to prepare topical nanoemulgel containing 2 % DEX and solubility-enhanced DEX via ternary inclusion complexation (DEX-SE-T) and to compare it with commercially available 5 % Ibuprofen gel as there is no topical formulation of DEX is available in the market currently. A pseudoternary phase diagram was constructed using the spontaneous water titration method. Blank and drug-loaded nanoemulgel were prepared using a high-speed homogenization method. All the formulations were evaluated in terms of particle size, pH, conductivity, viscosity, zeta potential, and ex vivo drug permeation. DEX loaded nanoemulgel yield enhanced in vitro skin permeation than the commercially available 5 % ibuprofen gel. The optimized nanoemulgel formulation (DEX-SE-T) was tested in in vivo anti-inflammatory models including cotton pellets-induced abdominal granuloma (chronic inflammation) and carrageenan-induced paw edema (acute inflammation). DEX-SE-T loaded nanoemulgel has improved in vivo anti-inflammatory activity as compared to ibuprofen gel. DEX-SE-T could be a promising option for effective topical treatment of inflammatory conditions.
ELSEVIER
0927-7765
1873-4367
2025
247

10.1016/j.colsurfb.2024.114407
Biophysics; Chemistry; Materials Science

WOS:001375588800001
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-recordWOS:001375588800001
title Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
title_short Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
title_full Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
title_fullStr Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
title_full_unstemmed Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
title_sort Dexibuprofen loaded into nanoemulsion based gel for topical application - In vitro characterization and in vivo anti-inflammatory evaluation
container_title COLLOIDS AND SURFACES B-BIOINTERFACES
language English
format Article
description Arthritic disease is one of the most common diseases in adults and a leading cause of joint degeneration. Dexibuprofen (DEX) is routinely used for the treatment of rheumatoid arthritis, acute postoperative pain, primary dysmenorrheal, and in lower back pain. However, it is poorly water soluble with compromised bioavailability, and hence has limited therapeutic activity. In order to overcome these issues, we studied the formulation and characterization of nanoemulsion based system i.e nanoemulgel of DEX. This study aimed to prepare topical nanoemulgel containing 2 % DEX and solubility-enhanced DEX via ternary inclusion complexation (DEX-SE-T) and to compare it with commercially available 5 % Ibuprofen gel as there is no topical formulation of DEX is available in the market currently. A pseudoternary phase diagram was constructed using the spontaneous water titration method. Blank and drug-loaded nanoemulgel were prepared using a high-speed homogenization method. All the formulations were evaluated in terms of particle size, pH, conductivity, viscosity, zeta potential, and ex vivo drug permeation. DEX loaded nanoemulgel yield enhanced in vitro skin permeation than the commercially available 5 % ibuprofen gel. The optimized nanoemulgel formulation (DEX-SE-T) was tested in in vivo anti-inflammatory models including cotton pellets-induced abdominal granuloma (chronic inflammation) and carrageenan-induced paw edema (acute inflammation). DEX-SE-T loaded nanoemulgel has improved in vivo anti-inflammatory activity as compared to ibuprofen gel. DEX-SE-T could be a promising option for effective topical treatment of inflammatory conditions.
publisher ELSEVIER
issn 0927-7765
1873-4367
publishDate 2025
container_volume 247
container_issue
doi_str_mv 10.1016/j.colsurfb.2024.114407
topic Biophysics; Chemistry; Materials Science
topic_facet Biophysics; Chemistry; Materials Science
accesstype
id WOS:001375588800001
url https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-recordWOS:001375588800001
record_format wos
collection Web of Science (WoS)
_version_ 1820775410734989312